Endo Settles Lidoderm Marketing Lawsuit for $171.9 Million

Endo Pharmaceuticals Pays Settlement for Off-Label Marketing of Lidoderm Pain Patch Endo Health Solutions Inc and its subsidiary Endo Pharmaceuticals have agreed to pay $171.9 million to settle False Claims allegations for off-label marketing of their pain patch, Lidoderm. Endo Pharmaceuticals is also a subsidiary of American Medical Systems, and … [Read more...]

BestLawyers.comAVBetter Business Bureau